Open Access

PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Event: ESC CONGRESS 2016
Topic: Atherosclerosis
Session type: Satellite Symposium
Sponsored by Amgen Cardiovascular
Date: 30 August 2016
Time: 12:45 - 13:45

Congress Session

4 presentations in this session

Introduction - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speaker: Professor J. Kastelein (Amsterdam, NL)
Thumbnail

PCSK9i: impacting on plaque regression?

Speaker: Professor W. Koenig (Munich, DE)
Thumbnail

PCSK9i: new horizons in CVD prevention?

Speaker: Professor K. Ray (London, GB)
Thumbnail

Conclusion - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speaker: Professor J. Kastelein (Amsterdam, NL)
Thumbnail

4 speakers from this session

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)
21 presentations
0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
1 follower

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

This platform is supported by

logo Novo Nordisk